Expert Opinion

Accelerating iPSC Allogeneic Cell Therapy Development: The Role of Allo Chassis™

March 27, 2025

Accelerating iPSC Allogeneic Cell Therapy Development: The Role of Allo ...

Introduction Cell therapies have surged to the forefront of modern medicine, primarily due to ...

GMP Principles in iPS Cell Line Development: A Key Foundation for Advancing Therapeutic Applications

February 17, 2025

GMP Principles in iPS Cell Line Development: A Key Foundation for ...

Introduction The manufacture of Advanced Therapy Medicinal Products (ATMPs) requires the ...

Gene-edited iPSC: the role of Automation in Cell Line Development

February 14, 2025

Gene-edited iPSC: the role of Automation in Cell Line Development

Precise gene editing is crucial for the development of cell-based therapies, particularly ...

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, Importance and Strategies

February 5, 2025

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, ...

Induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies hold significant ...

Development and characterization of iPSC-derived regulatory T cells – Towards an allogenic cell therapy for the treatment of autoimmunity and inflammatory conditions

December 3, 2024

Development and characterization of iPSC-derived regulatory T cells – ...

Regulatory T cells (Tregs) play a pivotal role in maintaining immune homeostasis and ...

Enhanced control of iPS cell critical quality attributes through analytical characterisation

September 30, 2024

Enhanced control of iPS cell critical quality attributes through ...

1 2 3 →